Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus

Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/atvbaha.118.310990
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Favorable Effects of Early Insulin Secretion by Nateglinide on Postprandial Hyperlipidemia in Patients With Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2006English

Impaired Postprandial Metabolism of Apolipoprotein B48-Containing Remnant Particles in Normolipidemic Subjects With Brittle Type 1 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2009English

Retrospective Analysis of an Insulin-To-Liraglutide Switch in Patients With Type 2 Diabetes Mellitus

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

The Cost-Effectiveness of Dulaglutide Versus Liraglutide in Patients With Type 2 Diabetes Mellitus in Taiwan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Determination of Renal Changes by Ultrasonography in Patients With Type-2 Diabetes Mellitus

2019English

Is a Switch From Insulin Therapy to Liraglutide Possible in Japanese Type 2 Diabetes Mellitus Patients?

Journal of Clinical Medicine Research
2014English

Effects of Fenofibrate in Patients With Type 2 Diabetes Mellitus Complicated by Diabetic Neuropathy

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

HLA-DRB1 Reduces the Risk of Type 2 Diabetes Mellitus by Increased Insulin Secretion

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2011English

Potential of Liraglutide in the Treatment of Patients With Type 2 Diabetes

Vascular Health and Risk Management
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy